Affiliation:
1. I.M. Sechenov First Moscow State Medical University
Abstract
There are presented modern data describing the current understanding of the pathogenesis of atopic dermatitis (AD): a genetic predisposition to atopy, disruptions of epidermal barrier integrity and a cascade of immune responses, contributing allergic inflammation in the skin. There are both described several mechanisms of acute and chronic phases of AD, the main directions of pathogenetically substantiated treatment of AD in children and indicated the prospects of new preparations specific blockers of proinflammatory cytokines involved in the development of AD - crisaborole, apremilast, dupilumab, lebrikizumab, tralokinumab, tezepelumab. There is especially presented in details external therapy of atopic skin lesions in children with the use of means of modern dermatological cosmetics.
Publisher
National Medical Research Center for Childrens Health
Reference68 articles.
1. DaVeiga S.P. Epidemiology of atopic dermatitis: a review. Allergy Asthma Proc. 2012; 33 (3): 227-34.
2. Orfali R.L., Shimizu M.M., Takaoka R., Zaniboni M.C., Ishizaki A.S., Costa A.A. et al. Atopic dermatitis in adults: clinical and epidemiological considerations. Rev. Assoc. Med. Bras. 2013; 59 (3): 270-5.
3. Spergel JM. Epidemiology of atopic dermatitis and atopic march in children. Immunol. Allergy Clin. North Am. 2010; 30 (3): 269-80.
4. Allergologiya i immunologiya. Klinicheskie rekomendatsii dlya pediatrov. 2-e izd. / Pod red. A.A. Baranova, R.M. Khaitova. M.; 2010.
5. Eichenfield L.F., Ellis C.N., Mancini A.J., Paller A.S., Simpson E.L. Atopic dermatitis: epidemiology and pathogenesis update. Semin. Cutan. Med. Surg. 2012; 31 (3, Suppl.): 3-5.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献